Deferiprone not beneficial for newly diagnosed Parkinson’s disease
For patients newly diagnosed with Parkinson disease, deferiprone is associated with worse scores in measures of parkinsonism. David Devos, M.D., Ph.D., from the University of Lille in France, and colleagues conducted a phase 2 trial involving patients with newly diagnosed Parkinson disease who had never received levodopa. Participants were randomly assigned to receive oral deferiprone […]
Continue Reading